regency centers corp. - REG
REG
Close Chg Chg %
75.48 -0.26 -0.34%
Closed Market
75.22
-0.26 (0.34%)
Volume: 2.23M
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: regency centers corp. - REG
REG Key Data
| Open $76.13 | Day Range 74.02 - 76.35 |
| 52 Week Range 63.44 - 78.18 | Market Cap $13.58B |
| Shares Outstanding 182.90M | Public Float 181.24M |
| Beta 0.96 | Rev. Per Employee N/A |
| P/E Ratio 34.53 | EPS $2.19 |
| Yield 380.23% | Dividend $0.76 |
| EX-DIVIDEND DATE Dec 15, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.44M |
REG Performance
| 1 Week | 3.22% | ||
| 1 Month | 7.89% | ||
| 3 Months | 7.81% | ||
| 1 Year | 1.62% | ||
| 5 Years | 53.17% |
REG Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
21
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 78.889 | |
| Number of Ratings | 21 | Current Quarters Estimate | 0.616 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 2.445 | |
| Last Quarter’s Earnings | 1.09 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.82 | Next Fiscal Year Estimate | 2.579 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 5 | 7 | 7 |
| Mean Estimate | 0.62 | 0.61 | 2.44 | 2.58 |
| High Estimates | 0.65 | 0.63 | 2.64 | 2.85 |
| Low Estimate | 0.58 | 0.58 | 2.27 | 2.28 |
| Coefficient of Variance | 4.56 | 3.38 | 4.45 | 6.58 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 9 | 9 | 10 |
| OVERWEIGHT | 4 | 3 | 4 |
| HOLD | 8 | 9 | 7 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Regency Centers Corp. - REG
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Regency Centers Corp. - REG
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 6, 2026 | Martin E. Stein Executive Chairman; Director | 2,069 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 6, 2026 | C. Ronald Blankenship Director | 112,351 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 6, 2026 | Alan Todd Roth E. Regional Pres. & COO | 4,414 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 6, 2026 | Peter David Linneman Director | 53,600 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 6, 2026 | Karin M. Klein Director | 23,198 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 6, 2026 | Lisa Palmer President and CEO; Director | 17,934 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 6, 2026 | Michael Mas EVP and CFO | 5,601 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 6, 2026 | Nicholas Wibbenmeyer W. Regional Pres. & CIO | 4,414 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2025 | Lisa Palmer President and CEO; Director | 139,923 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $73.26 per share | 10,250,758.98 |